Hims & Hers (NYSE:HIMS) stock tumbled 20% in post-market trading Monday after the company released its Q4 earnings report and 2025 guidance amid a possible FDA crackdown on its GLP-1 weight-loss ...
The stock tumbled after the company said it will put money into a rights issue for its two subsidiaries—Mahindra & Mahindra Financial Services (MMFSL) and Mahindra Lifespace Developers (MLDL). Listen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback